Infections in children with cancer: A continued need for the comprehensive physical examination

Journal of Pediatric Hematology/Oncology

Volumn 21, Issue 6, 1999, Pages 501-508

  Auletta, Jeffery J ^a   O'Riordan, Mary Ann ^a   Nieder, Michael L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Bacteremia; Disease states; Infection; Mortality; Neoplasms; Neutropenia; Pediatric oncology

Indexed keywords

ADOLESCENT; ARTICLE; BLOOD CULTURE; CANCER REGRESSION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL EXAMINATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INDWELLING CATHETER; INFECTION; INFECTION RATE; INFECTION RISK; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; OTITIS MEDIA; PRIORITY JOURNAL; SEPTICEMIA; SOLID TUMOR; TREATMENT INDICATION; URINARY TRACT INFECTION;

EID: 0033503421     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199911000-00010     Document Type: Article

References (30)

1. Freifeld AG, Hathorn JW, Pizzo PA. Infectious complications in the pediatric cancer patient. In: Pizzo PA, Poplack DG, eds. Principles and practice of pediatric oncology. Philadelphia: Lippincott, 1993:987-1019.
2. Funai N, Shimamoto Y, Tokunaga O, et al. Ten-year survey of incidence of infection as a cause of death in hematologic malignancies: Study of 90 autopsied cases. Acta Haematol 1995;93:25-30.
3. Inagaki J, Rodriguez V, Bodey GP. Causes of death in cancer patients. Cancer 1974;33:568-73.
4. Pizzo PA, Ladisch S, Simon RM, et al. Increasing incidence of gram-positive sepsis in cancer patients. Med Pediatr Oncol 1978; 5:241-4.
5. Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Haematol 1993;51:102-8.
6. Sculier JP, Weerts D, Klastersky J. Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol 1984;20(1):55-60.
7. Weinberger M, Pizzo PA. The evaluation and management of neutropenic patients with unexplained fever. In: Patrick CC, ed. Infections in immunocompromised infants and children. New York: Churchill Livingstone, 1992:335-56.
8. Chanock S. Evolving risk factors for infectious complications of cancer therapy. Hematol Oncol Clin North Am 1993;7(4):771-93.
9. Koll BS, Brown AE. Changing patterns of infections in the immunocompromised patient with cancer. Hematol Oncol Clin North Am 1993;7(4):753-69.
10. Bodey GP. Infection in cancer patients. A continuing association. Am J Med 1986;81(Suppl 1A):11-26.
11. Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.
12. Pizzo PA, Robichaud KJ, Wesley R, et al. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 1982;61(3):153-65.
13. Whimbey E, Kiehn TE, Brannon P, et al. Bacteremia and fungemia in patients with neoplastic disease. Am J Med 1987;82:723-30.
14. Lehrnbecher T, Foster C, Vazquez N, et al. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 1997;19:399-417.
15. Decker MD, Edwards KM. Central venous catheter infections. Pediatr Clin North Am 1988;35:579-612.
16. Morrison VA, Peterson BA, Bloomfield CD. Nosocomial septicemia in the cancer patient: The influence of central venous access devices, neutropenia, and type of malignancy. Med Pediatr Oncol 1990;18:209-16.
17. Petrilli AS, Melaragno R, Barros KVT, et al. Fever and neutropenia in children with cancer: A therapeutic approach related to the underlying disease. Pediatr Infect Dis J 1993;12:916-21.
18. Kaleida PH. The COMPLETES exam for otitis. Contemporary Pediatrics 1997;14(9):93-101.
19. Kahn HA, Sempos C. Follow-up studies: Person years. In: Statistical methods in epidemiology. New York: Oxford University Press, 1989:206-25.
20. Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. J Infect Dis 1990;161:397-401.
21. Roberts JA. Factors predisposing to urinary tract infections in children. Pediatr Nephrol 1996;10:517-22.
22. Tolkoff-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host: Lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am 1997;11:707-17.
23. Stamm WE, Wagner KF, Amsel R, et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980;303:409-15.
24. Kass EH. Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract. Am J Med 1955;18:764-81.
25. Sanford JP, Favour CD, Mayo FH, et al. Evaluation of the 'positive' urine culture: An approach to the differentiation of significant bacteria from contaminants. Am J Med 1956;20:88-93.
26. Stamm WE, Counts GW, Running KR, et al. Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982;307: 463-8.
27. Maschmeyer G, Hiddemann W, Link H, et al. Management of infections during intensive treatment of hematologic malignancies. Ann Hematol 1997;75:9-16.
28. Aledo A, Heller G, Ren L, et al. Septicemia and septic shock in pediatric patients: 140 consecutive cases on a pediatric hematology-oncology service. J Pediatr Hematol Oncol 1998;20:215-21.
29. Lucas KG, Brown AE, Armstrong D, et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996;77:791-8.
30. Klastersky J, Zinner SH, Calandra T, et al. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: Lessons from four EORTC Trials. Eur J Cancer Clin Oncol 1988;24(Suppl 1): 35-45.